| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 54.0205 | 58 |
| GSM780708 | Untreated after 4 days (C2_1) | 70.8383 | 69 |
| GSM780709 | Untreated after 4 days (C3_1) | 60.7105 | 65 |
| GSM780719 | Untreated after 4 days (C1_2) | 58.2498 | 63 |
| GSM780720 | Untreated after 4 days (C2_2) | 80.7233 | 72 |
| GSM780721 | Untreated after 4 days (C3_2) | 63.3611 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 65.2086 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 64.333 | 67 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 67.6319 | 68 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 72.3511 | 70 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 67.5617 | 68 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 61.7574 | 66 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.9515 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.7389 | 56 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 56.6795 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 60.4355 | 65 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 63.4166 | 66 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 61.7446 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 87.0428 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 73.7455 | 70 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 72.9902 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 89.2859 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 68.7871 | 69 |